A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis
- First Posted Date
- 2007-10-10
- Last Posted Date
- 2013-04-22
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 923
- Registration Number
- NCT00541658
- Locations
- π΅π±
Research Site, Warszawa, Poland
π§πͺResearch Facility, Diepenbeek, Belgium
A Comparison of Once a Day Dose Compared to 2 Doses/Day
- Conditions
- Ulcerative Colitis
- Interventions
- First Posted Date
- 2007-07-23
- Last Posted Date
- 2013-04-22
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 1027
- Registration Number
- NCT00505778
- Locations
- πΊπΈ
Research Site, Hackensack, New Jersey, United States
π΅π·Research Facility, San Juan, Puerto Rico
Study of Safety and Efficacy of an Oral Contraceptive
- First Posted Date
- 2007-05-24
- Last Posted Date
- 2013-04-22
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 1700
- Registration Number
- NCT00477633
- Locations
- πΊπΈ
Warner Chilcott Investigational Site, Virginia Beach, Virginia, United States
Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women
- Conditions
- Hypoactive Sexual Desire Disorder
- Interventions
- Drug: Placebo patchDrug: Testosterone Transdermal System
- First Posted Date
- 2007-04-30
- Last Posted Date
- 2011-12-15
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 1271
- Registration Number
- NCT00467259
- Locations
- πΊπΈ
Research Facility, Tacoma, Washington, United States
πΊπΈStudy Facility, Richmond, Virginia, United States
πΊπΈSite Facility, Seattle, Washington, United States
Study of Safety and Efficacy of an Oral Contraceptive
- First Posted Date
- 2006-10-24
- Last Posted Date
- 2013-04-22
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 1683
- Registration Number
- NCT00391807
- Locations
- πΊπΈ
Warner Chilcott Investigational Site, Tacoma, Washington, United States
Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method
- First Posted Date
- 2006-10-11
- Last Posted Date
- 2012-01-11
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 161
- Registration Number
- NCT00386360
- Locations
- π¬π§
Research Facility, Cambridge, United Kingdom
Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen
- Conditions
- Hypoactive Sexual Desire Disorder
- Interventions
- Drug: PlaceboDrug: Testosterone
- First Posted Date
- 2006-10-04
- Last Posted Date
- 2013-04-17
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 272
- Registration Number
- NCT00384046
- Locations
- π¬π§
Research Facility, Warks, United Kingdom
π¬π§Site Facility, Headington, Oxford, United Kingdom
Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido
- Conditions
- Hypoactive Sexual Desire Disorder (HSDD)
- Interventions
- Drug: Testosterone Transdermal SystemDrug: Placebo patch
- First Posted Date
- 2006-07-10
- Last Posted Date
- 2013-04-17
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 549
- Registration Number
- NCT00349791
- Locations
- π¨π¦
Research Facility, Quebec, Canada
A Double Blind Study for the Treatment of Acute Ulcerative Colitis
- First Posted Date
- 2006-07-10
- Last Posted Date
- 2013-04-17
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 772
- Registration Number
- NCT00350415
- Locations
- πΊπ¦
Research Facility, Zaporizhzhya, Ukraine
π±πΉResearch FacilityPanevezys, Panevezys, Lithuania
Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido
- Conditions
- Hypoactive Sexual Desire Disorder
- Interventions
- Drug: Placebo patchDrug: Testosterone Transdermal System
- First Posted Date
- 2006-06-20
- Last Posted Date
- 2013-04-17
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 610
- Registration Number
- NCT00338312
- Locations
- πΊπΈ
Research Facility, Denver, Colorado, United States